The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

Immunotoxicological Effects of Aripiprazole: In vivo and In vitro Studies

  • Baek, Kwang-Soo (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Ahn, Shinbyoung (Central Institute, GCB) ;
  • Lee, Jaehwi (College of Pharmacy, Chung-Ang University) ;
  • Kim, Ji Hye (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Kim, Han Gyung (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Kim, Eunji (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Kim, Jun Ho (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Sung, Nak Yoon (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Yang, Sungjae (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Kim, Mi Seon (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Hong, Sungyoul (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Kim, Jong-Hoon (Department of Veterinary Physiology, College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University) ;
  • Cho, Jae Youl (Department of Genetic Engineering, Sungkyunkwan University)
  • Received : 2015.03.24
  • Accepted : 2015.06.02
  • Published : 2015.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Aripiprazole (ARI) is a commonly prescribed medication used to treat schizophrenia and bipolar disorder. To date, there have been no studies regarding the molecular pathological and immunotoxicological profiling of aripiprazole. Thus, in the present study, we prepared two different formulas of aripiprazole [Free base crystal of aripiprazole (ARPGCB) and cocrystal of aripiprazole (GCB3004)], and explored their effects on the patterns of survival and apoptosis-regulatory proteins under acute toxicity and cytotoxicity test conditions. Furthermore, we also evaluated the modulatory activity of the different formulations on the immunological responses in macrophages primed by various stimulators such as lipopolysaccharide (LPS), pam3CSK, and poly(I:C) via toll-like receptor 4 (TLR4), TLR2, and TLR3 pathways, respectively. In liver, both ARPGCB and GCB3004 produced similar toxicity profiles. In particular, these two formulas exhibited similar phospho-protein profiling of p65/nuclear factor $(NF)-{\kappa}B$, c-Jun/activator protein (AP)-1, ERK, JNK, p38, caspase 3, and bcl-2 in brain. In contrast, the patterns of these phospho-proteins were variable in other tissues. Moreover, these two formulas did not exhibit any cytotoxicity in C6 glioma cells. Finally, the two formulations at available in vivo concentrations did not block nitric oxide (NO) production from activated macrophage-like RAW264.7 cells stimulated with LPS, pam3CSK, or poly(I:C), nor did they alter the morphological changes of the activated macrophages. Taken together, our present work, as a comparative study of two different formulas of aripiprazole, suggests that these two formulas can be used to achieve similar functional activation of brain proteins related to cell survival and apoptosis and immunotoxicological activities of macrophages.

Keywords

References

  1. Moore TJ, Glenmullen J, Mattison DR. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med. 2014;174:1930-1933. https://doi.org/10.1001/jamainternmed.2014.5262
  2. Takaki M, Ujike H. Aripiprazole is effective for treatment of delayed sleep phase syndrome. Clin Neuropharmacol. 2014;37: 123-124. https://doi.org/10.1097/WNF.0000000000000035
  3. Kling RC, Tschammer N, Lanig H, Clark T, Gmeiner P. Active-state model of a dopamine D2 receptor-Gai complex stabilized by aripiprazole-type partial agonists. PLoS One. 2014;9:e100069. https://doi.org/10.1371/journal.pone.0100069
  4. De Berardis D, Fornaro M, Serroni N, Marini S, Piersanti M, Cavuto M, Valchera A, Mazza M, Girinelli G, Iasevoli F, Perna G, Martinotti G, Di Giannantonio M. Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole. Recent Pat Endocr Metab Immune Drug Discov. 2014;8:30-37. https://doi.org/10.2174/1872214807666131229125700
  5. Arunagiri P, Rajeshwaran K, Shanthakumar J, Tamilselvan T, Balamurugan E. Combination of omega-3 Fatty acids, lithium, and aripiprazole reduces oxidative stress in brain of mice with mania. Biol Trace Elem Res. 2014;160:409-417. https://doi.org/10.1007/s12011-014-0067-8
  6. Asmari AA, Arshaduddin M, Elfaki I, Kadasah S, Robayan AA, Asmary SA. Aripiprazole an atypical antipsychotic protects against ethanol induced gastric ulcers in rats. Int J Clin Exp Med. 2014;7:2031-2044.
  7. Sarvari AK, Vereb Z, Uray IP, Fesus L, Balajthy Z. Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro. Biochem Biophys Res Commun. 2014;450:1383-1389. https://doi.org/10.1016/j.bbrc.2014.07.005
  8. Kato TA, Monji A, Yasukawa K, Mizoguchi Y, Horikawa H, Seki Y, Hashioka S, Han YH, Kasai M, Sonoda N, Hirata E, Maeda Y, Inoguchi T, Utsumi H, Kanba S. Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia. Schizophr Res. 2011;129: 172-182. https://doi.org/10.1016/j.schres.2011.03.019
  9. Picada JN, Dos Santos Bde J, Celso F, Monteiro JD, Da Rosa KM, Camacho LR, Vieira LR, Freitas TM, Da Silva TG, Pontes VM, Pereira P. Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice. Acta Pharmacol Sin. 2011;32:1225-1232. https://doi.org/10.1038/aps.2011.77
  10. Dorado P, de Andres F, Naranjo ME, Penas-Lledo EM, Gonzalez I, Gonzalez AP, de la Rubia A, Llerena A. Highperformance liquid chromatography method using ultraviolet detection for the quantification of aripiprazole and dehydroaripiprazole in psychiatric patients. Drug Metabol Drug Interact. 2012;27:165-170.
  11. Kim JR, Seo HB, Cho JY, Kang DH, Kim YK, Bahk WM, Yu KS, Shin SG, Kwon JS, Jang IJ. Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients. Br J Clin Pharmacol. 2008;66:802-810. https://doi.org/10.1111/j.1365-2125.2008.03223.x
  12. Thakuria R, Delori A, Jones W, Lipert MP, Roy L, Rodriguez-Hornedo N. Pharmaceutical cocrystals and poorly soluble drugs. Int J Pharm. 2013;453:101-125. https://doi.org/10.1016/j.ijpharm.2012.10.043
  13. Seo SJ, Cho JY, Jeong YH, Choi YS. Effect of Korean red ginseng extract on liver damage induced by short-term and long-term ethanol treatment in rats. J Ginseng Res. 2013;37:194-200. https://doi.org/10.5142/jgr.2013.37.194
  14. Kim BJ. Involvement of melastatin type transient receptor potential 7 channels in ginsenoside Rd-induced apoptosis in gastric and breast cancer cells. J Ginseng Res. 2013;37:201-209. https://doi.org/10.5142/jgr.2013.37.201
  15. Hwang YJ, Chung ML, Sohn UD, Im C. Cytotoxicity and structure-activity relationships of naphthyridine derivatives in human cervical cancer, leukemia, and prostate cancer. Korean J Physiol Pharmacol. 2013;17:517-523. https://doi.org/10.4196/kjpp.2013.17.6.517
  16. Kim MY, Cho JY. 20S-dihydroprotopanaxatriol modulates functional activation of monocytes and macrophages. J Ginseng Res. 2013;37:300-307. https://doi.org/10.5142/jgr.2013.37.300
  17. Kim MY, Cho JY. 20S-dihydroprotopanaxadiol, a ginsenoside derivative, boosts innate immune responses of monocytes and macrophages. J Ginseng Res. 2013;37:293-299. https://doi.org/10.5142/jgr.2013.37.293
  18. Youn CK, Park SJ, Lee MY, Cha MJ, Kim OH, You HJ, Chang IY, Yoon SP, Jeon YJ. Silibinin inhibits LPS-Induced macrophage activation by blocking p38 MAPK in RAW 264.7 cells. Biomol Ther (Seoul). 2013;21:258-263. https://doi.org/10.4062/biomolther.2013.044
  19. Lee JW, Kim NH, Kim JY, Park JH, Shin SY, Kwon YS, Lee HJ, Kim SS, Chun W. Aromadendrin inhibits lipopolysaccharide-Induced nuclear translocation of NF-${\kappa}$B and phosphorylation of JNK in RAW 264.7 macrophage cells. Biomol Ther (Seoul). 2013;21:216-221. https://doi.org/10.4062/biomolther.2013.023
  20. Eo SH, Cho H, Kim SJ. Resveratrol inhibits nitric oxideinduced apoptosis via the NF-Kappa B pathway in rabbit articular chondrocytes. Biomol Ther (Seoul). 2013;21:364-370. https://doi.org/10.4062/biomolther.2013.029
  21. Cho KS, Kwon KJ, Jeon SJ, Joo SH, Kim KC, Cheong JH, Bahn GH, Kim HY, Han SH, Shin CY, Yang SI. Transcriptional upregulation of plasminogen activator inhibitor-1 in rat primary astrocytes by a proteasomal inhibitor MG132. Biomol Ther (Seoul). 2013;21:107-113. https://doi.org/10.4062/biomolther.2012.102
  22. Peng L, Gao Y, Xue YN, Huang SW, Zhuo RX. Cytotoxicity and in vivo tissue compatibility of poly(amidoamine) with pendant aminobutyl group as a gene delivery vector. Biomaterials. 2010;31:4467-4476. https://doi.org/10.1016/j.biomaterials.2010.02.031
  23. Kim JH, Lee YG, Yoo S, Oh J, Jeong D, Song WK, Yoo BC, Rhee MH, Park J, Cha SH, Hong S, Cho JY. Involvement of Src and the actin cytoskeleton in the antitumorigenic action of adenosine dialdehyde. Biochem Pharmacol. 2013;85:1042-1056. https://doi.org/10.1016/j.bcp.2013.01.012
  24. Lin WL, Wang CJ, Tsai YY, Liu CL, Hwang JM, Tseng TH. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch Toxicol. 2000;74:467-472. https://doi.org/10.1007/s002040000148
  25. Aripiprazole: new drug. Just another neuroleptic. Prescrire Int. 2005;14:163-167.
  26. Chu CS, Tzeng NS, Chang HA, Chang CC, Chen TY. Killing two birds with one stone: the potential role of aripiprazole for patients with comorbid major depressive disorder and nicotine dependence via altering brain activity in the anterior cingulate cortex. Med Hypotheses. 2014;83:407-409. https://doi.org/10.1016/j.mehy.2014.07.008
  27. Kim MY, Yoo BC, Cho JY. Ginsenoside-Rp1-induced apolipoprotein A-1 expression in the LoVo human colon cancer cell line. J Ginseng Res. 2014;38:251-255. https://doi.org/10.1016/j.jgr.2014.06.003
  28. Lee YG, Chain BM, Cho JY. Distinct role of spleen tyrosine kinase in the early phosphorylation of inhibitor of kappaB alpha via activation of the phosphoinositide-3-kinase and Akt pathways. Int J Biochem Cell Biol. 2009;41:811-821. https://doi.org/10.1016/j.biocel.2008.08.011
  29. Padiyar GS, Seshadri TP. Preference for syn conformation: crystal structures of free acid and ammonium salt of adenosine 2'-monophosphate: an inhibitor of RNase T1. J Biomol Struct Dyn. 1998;15:793-802. https://doi.org/10.1080/07391102.1998.10508993
  30. Yang Y, Yu T, Lian YJ, Ma R, Yang S, Cho JY. Nitric oxide synthase inhibitors: a review of patents from 2011 to the present. Expert Opin Ther Pat. 2015;25:49-68.
  31. Kim YM, Kim JH, Kwon HM, Lee DH, Won MH, Kwon YG, Kim YM. Korean Red Ginseng protects endothelial cells from serum-deprived apoptosis by regulating Bcl-2 family protein dynamics and caspase S-nitrosylation. J Ginseng Res. 2013;37:413-424. https://doi.org/10.5142/jgr.2013.37.413
  32. Kim EH, Kim IH, Ha JA, Choi KT, Pyo S, Rhee DK. Antistress effect of red ginseng in brain cells is mediated by TACE repression via PADI4. J Ginseng Res. 2013;37:315-323. https://doi.org/10.5142/jgr.2013.37.315
  33. Kim JY, Lee YG, Kim MY, Byeon SE, Rhee MH, Park J, Katz DR, Chain BM, Cho JY. Src-mediated regulation of inflammatory responses by actin polymerization. Biochem Pharmacol. 2010;79:431-443. https://doi.org/10.1016/j.bcp.2009.09.016
  34. Kato TA, Monji A, Mizoguchi Y, Hashioka S, Horikawa H, Seki Y, Kasai M, Utsumi H, Kanba S. Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia? Mini Rev Med Chem. 2011;11:565-574. https://doi.org/10.2174/138955711795906941